Skip to content
Search
Search
Close this search box.
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Menu
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
Menu
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
Investors
Technical Support
Contact Us
Menu
Investors
Technical Support
Contact Us
Investors
Contact Us
Menu
Investors
Contact Us
Schedule a Meeting
Search
Search
Close this search box.
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Menu
Products & Technology
T2Dx Instrument
T2Bacteria Panel
T2Candida Panel
T2Biothreat Panel
T2MR Technology
Product Pipeline
BARDA
T2Resistance Panel
T2Lyme Panel
T2Cauris Panel
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Case Studies
Webinars & Videos
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships
International Distributors
FAQ
Media Resources
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
Menu
Products & Technology
T2Bacteria Panel
T2Candida Panel
T2Resistance Panel
T2Biothreat Panel
T2Dx Instrument
T2MR Technology
Product Pipeline
T2Lyme Panel
T2Cauris Panel RUO
Healthcare Challenges
Sepsis
Antimicrobial Resistance
Lyme Disease
Resources
Publications
Webinars & Videos
Case Studies
About T2
Our Company
Our Mission
News
Leadership
Careers
Events
Research Partnerships International
Distributors
FAQ
Media Resources
source:
News
T2 Biosystems Seeks FDA Clearance of Sepsis Test
With FDA Filing, Lexington Firm Targets a Scourge of Hospitals: Sepsis
T2 Biosystems Files 510(k) for T2Bacteria Panel
T2 Biosystems Submits 510(k) Application for Bacteria Panel
The Bloomberg Baystate Business Hour
Exclusive: T2 Biosystems CEO Says Euro Approval on Sepsis Bacteria Test a ‘Big Milestone’
T2 Biosystems Receives CE Mark for Bacterial Panel
T2 Biosystems Receives CE Mark for Bacterial Panel
T2 Biosystems wins CE Mark for MR-based bacteria detector, closing in on FDA bid
Hope For People with Chronic Lyme? Scientists Rush to Develop New Tests
Fastest-Growing Public Companies in Massachusetts
T2 Biosystems’ T2MR Detects Lyme Disease-Causing Bacteria in Blood
←
Previous
Next
→